Propionic acid derivative 8, which was designed and synthesized based on putative pharmacophores of known PPARgamma- and PPARalpha-selective compounds, exhibits potent dual PPARalpha/gamma agonist activity as demonstrated by in vitro binding and dose overlap in the newly introduced EOB mouse model for glucose lowering and lipid/cholesterol homeostasis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jm0155188 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!